Expert Opinion on Biological Therapy

Papers
(The H4-Index of Expert Opinion on Biological Therapy is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Biosimilars and interchangeable biosimilars: facts every prescriber, payor, and patient should know. Insulins perspective104
Biosimilars for retinal diseases: United States-Europe awareness survey (Bio-USER – survey)51
Statement of Retraction49
Bispecific antibodies for the treatment of hemophilia A47
Novel formats of antibody conjugates: recent advances in payload diversity, conjugation, and linker chemistry41
Belimumab for the treatment of pediatric patients with lupus nephritis39
Addressing high dose AAV toxicity – ‘one and done’ or ‘slower and lower’?36
Aflibercept biosimilars – so near, yet so far33
Biologic therapies for chronic obstructive pulmonary disease31
Bispecific antibodies for immune cell retargeting against cancer31
Pharmacokinetic and pharmacodynamic similarity of biosimilar natalizumab (PB006) to its reference medicine: a randomized controlled trial30
The potential for medical therapies to address fistulizing Crohn’s disease: a state-of-the-art review30
Predisposition to conjunctivitis and male sex reduces drug survival of dupilumab in adults and adolescents30
The history of Crohn’s perianal fistula treatment with mesenchymal stem cells: the story of darvadstrocel29
Biological therapies for the treatment of psoriasis in pediatrics29
Antibody-drug conjugates (ADCs) targeting TROP-2 in lung cancer27
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn’s disease: results from an Italian multicenter study26
The ULTIMATE trials: are there advantages of ublituximab over teriflunomide in relapsing multiple sclerosis?25
Luspatercept in low-risk myelodysplastic syndromes: a paradigm shift in treatment strategies24
A comprehensive overview on the anti-inflammatory, antitumor, and ferroptosis functions of bromelain: an emerging cysteine protease22
Cell-based therapies for the treatment of sports injuries of the upper limb22
Elotuzumab in multiple myeloma21
Biologic insights from single-cell studies of psoriasis and psoriatic arthritis21
Perceptions of airway gene therapy for cystic fibrosis21
0.16963195800781